Plunkett Research Online: Eupraxia Pharmaceuticals Inc

EUPRAXIA PHARMACEUTICALS INC (EPRX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverag.....


EUPRAXIA PHARMACEUTICALS INC

Ticker: EPRX
Exchange: TSX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 250 590-3968
Fax: 250 590-2588
Address: 204 - 2590 Cadboro Bay
Victoria, BC Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

James HelliwellCEO/Co-Founder/Director
Bruce CousinsCFO/President
See More
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverag.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture